Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patterns of Medication Discontinuation and Their Impact on Accessibility in Brazil (2014–2024)

  • By

  • Raphaella Oliveira Martins de Lima

  • Esther Ramos Silva

  • Isabel C. M. Emmerick

  • Danielle Maria de Souza Serio dos Santos

  • Isabella Piassi Dias Godói

  • Ana Cristina Viana Campos

  • Luisa Arueira Chaves

  • August 22, 2026

Share

  • 1

    The WHO identified drug shortages as a global issue in 2014, impacting health systems and patient care.

  • 2

    Brazil's drug discontinuation panel is the primary tool for managing notifications of medicine production interruptions.

  • 3

    Under Brazilian law, manufacturers must report any discontinuation of production or importation of medicines.

  • 4

    The study analyzes data from ANVISA's discontinuation panel to assess patterns and reasons for medicine discontinuation in Brazil.

  • 5

    Brazil's approach focuses on monitoring discontinuations rather than shortages, which may help prevent access issues.

Original Source(s)

Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024)

  • by Raphaella Oliveira Martins de Lima, Esther Ramos Silva, Isabel C. M. Emmerick, Danielle Maria de Souza Serio dos Santos, Isabella Piassi Dias Godói, Ana Cristina Viana Campos, Luisa Arueira Chaves

  • August 22, 2026

Related Content

Ethics of Autonomous AI Clinical Trials: Delphi Study

HHS Launches First National Autism Missing and Endangered Person Alert Initiative

Does kinematic alignment better restore gait in CPAK type 1 TKA?

Overall knee kinematics were similar between alignment strategies, but subgroup findings pointed to more physiologic gait with kinematic alignment.